Gamma Delta T Cells and their role in the acute phase reaction to intravenous bisphosphonates

Phase 1

• Conditions: Patients with osteoporosis or Paget's disease of bone; MedDRA version: 9.1 Level: LLT Classification code 10031282 Term: Osteoporosis; MedDRA version: 9.1 Level: LLT Classification code 10033362 Term: Paget's disease

• Registration Number: EUCTR2007-005647-14-GB
• Lead Sponsor: Cardiff University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-02-22
• Study Completion: 2008-05-14
• Last Update Posted: 25 November 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Due to receive or currently receiving or have received intravenous bisphosphonates for the treatment of osteoporosis or paget's disease of bone
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Unable to give informed consent
Poor venous access

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified